Cadence Design Systems Aktie
WKN: 873567 / ISIN: US1273871087
25.10.2023 16:54:44
|
Pfizer To Expand Access To Cadence Products And Programming Toolkits For Advanced Molecular Design
(RTTNews) - Pfizer Inc. has signed an agreement to extend and expand access to Cadence products and programming toolkits for advanced molecular design, Cadence Molecular Sciences, a business unit of Cadence Design Systems (CDNS), said in a statement.
Cadence Molecular Sciences' physics-and AI-based modeling and cheminformatics computational software is an enabler of early-stage drug discovery innovation. The software is used by major pharmaceutical and biotech companies worldwide to help accelerate and advance therapeutic research, Cadence said.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Cadence Design Systems Inc.mehr Nachrichten
Analysen zu Cadence Design Systems Inc.mehr Analysen
Aktien in diesem Artikel
Cadence Design Systems Inc. | 254,70 | -0,24% |
|
Pfizer Inc. | 20,78 | -0,43% |
|